一種新型生命體征監測儀綜合了二氧化碳描記、脈搏血氧儀以及血壓監測等方面的進展。這種儀器已經獲得了美國食品藥品管理局的批準。

這種CAS 750C是由CAS醫療公司研制開發的，配備了以色列Oridion 公司的Microstream 二氧化碳描記、美國Masimo公司的脈搏血氧儀以及CAS MAXNIBP血壓監測技術。

這種重量輕、便攜式監測儀具有多種用途，從急癥護理到程序化鎮靜治療。Microstream capnography和采集樣本輔助功能在臨床上十分有用，可以是峰谷CO2的監測效率更高，也更加有效。CAS公司聲稱。聯合應用Maximo SET脈搏血氧儀技術，這種監測儀為輔助呼吸和氧療制定了新的標準。這家公司的產品在全球范圍內得到了廣泛應用。

CAS公司總裁兼首席執行官Louis P. Scheps評論說：“我們十分高興的宣布，這種750C產品加入到我們公司的生命體征監測產品生產線。使用終末峰谷CO2檢測技術，我們進一步擴大了檢測能力，為臨床醫生提供更多的患者生命體征信息?！?BR> 
Novel Vital Signs Monitor
 
A new vital signs monitor incorporates advances in capnography, pulse oximetry, and blood pressure monitoring. The monitor has been cleared by the U.S. Food and Drug Administration (FDA).

The CAS 750C, developed by CAS Medical Systems, Inc. (Branford, CT, USA), incorporates the Microstream capnography of Oridion Systems, Ltd. (Jerusalem, Israel), the pulse oximetry of Masimo Corp. (Irvine, CA, USA), and the CAS MAXNIBP blood-pressure monitoring technology.

The lightweight, portable monitor is designed for a variety of applications, ranging from emergency care to procedural sedation. The Microstream capnography and sampling accessories provide clinical advantages that make tidal CO2 monitoring more efficient and effective. Combined with the Maximo SET pulse oximetry technology, the monitor sets a new standard in monitoring ventilation and oxygenation, states CAS. The company’s products are used by doctors worldwide.

“We are very pleased to announce the addition of the 750C to our vital signs monitoring product line,” commented Louis P. Scheps, president and CEO of CAS Medical Systems, Inc. “With end tidal CO2 technology, we have further expanded our measurement capabilities and the breadth of information we can provide to clinicians regarding their patients’ vital statistics.